
An antibody infusion being tested for preventing HIV does not seem to thwart most infections — but its success against certain strains of the virus suggests researchers are on the right track. That’s the takeaway from a clinical trial that put the antibody, called VRC01, to the test in 2,700 people at high risk of… read on > read on >